The Journal of Allergy and Clinical Immunology: In Practice
Original ArticleVery Poorly Controlled Asthma in Urban Minority Children: Lessons Learned
Section snippets
Design and study setting
This descriptive study was a subanalysis of data obtained from an ongoing randomized controlled trial testing the efficacy of an ED/home-based environmental control intervention in young inner-city children who had frequent ED visits for asthma.21 Families of children aged 3 to 12 years were recruited and enrolled during an asthma ED visit from August 2013 through February 2016. Inclusion criteria were physician-diagnosed persistent and uncontrolled (NWC or VPC) asthma based on current national
Baseline health and sociodemographic characteristics
Children were primarily male (65%), black (93%), and Medicaid insured (94%) with a mean age of 6.4 ± 2.7 years at baseline (Table I). Caregivers were the child's biological mother (92%), single (74%), had a mean age of 31.3 ± 7.5 years, were high school graduates or higher educated (80%), and poor based on a household income of less than $30,000 (61%). At baseline most children were categorized with moderate persistent (46%) or severe persistent (29%) asthma and most were categorized with VPC
Discussion
In a group of young urban minority children with persistent asthma and high ED utilization, almost half (46%) had persistent VPC asthma over 6 months. The lack of improvement in asthma control confirms the challenge in managing uncontrolled asthma in urban minority children without individualizing treatment for each child. Personalized management should include identifying biomarkers of allergen sensitization and environmental exposures, and assessing allergic comorbidities, as performed in our
Acknowledgements
We appreciate Mary Gates, Amanda Manning, and Cheyenne McCray for the collection of data and the families for their participation in the study.
References (34)
- et al.
Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma
J Allergy Clin Immunol
(2014) Allergic rhinitis and asthma: how important is the link?
J Allergy Clin Immunol
(1997)Rhinitis and asthma: evidence for respiratory system integration
J Allergy Clin Immunol
(2003)- et al.
Psychosocial factors in severe pediatric asthma
Immunol Allergy Clin North Am
(2016) - et al.
Stress and quality of life in urban caregivers of children with poorly controlled asthma: a longitudinal analysis
J Pediatr Health Care
(2015) - et al.
Factors associated with poor controller medication use in children with high asthma emergency department use
Ann Allergy Asthma Immunol
(2017) - et al.
Status of childhood asthma in the United States, 1980-2007
Pediatrics
(2009) The National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. NIH Publication No. 07-4051
(2007)- et al.
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study
J Allergy Clin Immunol
(2009) - et al.
Asthma that is not well controlled is associated with increased healthcare utilization and decreased quality of life
J Asthma
(2011)
Caregiver perception of asthma management of children in the context of poverty
J Asthma
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observation cohort
Curr Respir Care Rep
Phenotype-driven therapeutics in severe asthma
Curr Allergy Asthma Rep
Asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma
Ann Allergy Asthma Immunol
Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial
J Allergy Clin Immunol Pract
Underdiagnosed and undertreated allergic rhinitis in urban school-aged children with asthma
Ped Allergy Immunol Pulmonol
A community study of factors related to poorly controlled asthma among Brazilian urban children
PLos One
Cited by (7)
Pattern of medication use in children with very poorly controlled asthma
2019, Annals of Allergy, Asthma and ImmunologyThe Journal of Allergy and Clinical Immunology: In Practice 2018 Highlights
2019, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Risk factors associated with very poorly controlled asthma in children are incompletely known. Butz et al39 studied 222 children from an ED encounter through 6-month follow-up; 53% of children at baseline and 46% at follow-up were classified with very poorly controlled asthma. In multivariable analyses, the risks for very poorly controlled asthma were the following: (1) 2.4-fold increase in children with allergic rhinitis, (2) 2.8-fold increase in those with 2 or more primary care asthma visits in the previous 3 months, (3) 2.1-fold increase if caregivers expressed worry regarding the side effects of the medication, and (4) 3-4-fold increase when control was measured during the fall or spring season, respectively.
Maximizing the role of the nurse: Strategies to address gaps in asthma care in schools
2020, Journal of Pediatric NursingCitation Excerpt :A disparate burden of childhood asthma is seen among socioeconomically-disadvantaged youth, who often live in urban areas with high poverty rates (Milligan, Matsui, & Sharma, 2016). In addition, African-American, male, school-aged children living in poverty are at high risk for poorly controlled asthma, (Butz et al., 2018). In Tennessee 11.5% of all children ages 0–17 years have an asthma diagnosis (Bloom, Cohen, & Freeman, 2012).
Rethinking Access to Care
2018, Journal of Allergy and Clinical Immunology: In PracticeJournal Club-The intersection of racial/ethnic disparities in coronavirus disease 2019 and COPD
2020, Chronic Obstructive Pulmonary Diseases
This work was supported by the National Institute of Nursing Research, National Institutes of Health (NIH) (grant no. NR013486). The study is registered with ClinicalTrials.gov with number NCT01981564. This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant number UL1 TR 000424-06 from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH, and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Johns Hopkins ICTR, NCATS or NIH.
Conflicts of interest: A. M. Butz, M. Bellin, S. S. Mudd, J. Ogborn, C. Lewis-Land, and M. E. Bollinger have received research support from the National Institutes of Health (NIH), National Institute of Nursing Research (NINR) (grant no. NR013486). M. Tsoukleris has received consultancy fees from Johns Hopkins University School of Medicine and has received fees for the management of pharmacy data collection processes and related analysis. J. Kub has received research support from the NIH, NINR (grant no. NR013486), and receives royalties for a textbook. T. Morphew has received research support from the NIH, NINR (grant no. NR013486), and has received consultancy fees, fees for participation in review activities, and payment for writing/reviewing the manuscript from Morphew Consulting, LLC.